Insider Transactions in Q1 2023 at Phreesia, Inc. (PHR)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2023
|
Balaji Gandhi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,428
+19.85%
|
-
|
|
Mar 17
2023
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Indirect |
18
-0.34%
|
$594
$33.65 P/Share
|
|
Mar 16
2023
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Indirect |
192
-1.74%
|
$6,528
$34.81 P/Share
|
|
Mar 15
2023
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Indirect |
26
-0.47%
|
$858
$33.84 P/Share
|
|
Feb 02
2023
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
300
-0.3%
|
$12,000
$40.0 P/Share
|
|
Feb 02
2023
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
11,378
-5.25%
|
$443,742
$39.55 P/Share
|
|
Feb 02
2023
|
Randy Rasmussen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,765
-3.17%
|
$190,600
$40.0 P/Share
|
|
Feb 02
2023
|
Michael J. Davidoff SVP, Payer Business |
SELL
Open market or private sale
|
Direct |
7,513
-3.6%
|
$293,007
$39.33 P/Share
|
|
Jan 31
2023
|
Lainie Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
266
+1.12%
|
$9,842
$37.49 P/Share
|
|
Jan 31
2023
|
Gillian Munson Director |
BUY
Grant, award, or other acquisition
|
Direct |
266
+1.17%
|
$9,842
$37.49 P/Share
|
|
Jan 31
2023
|
Edward L Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
266
+0.7%
|
$9,842
$37.49 P/Share
|
|
Jan 31
2023
|
Michael J. Davidoff SVP, Payer Business |
SELL
Open market or private sale
|
Direct |
3,265
-3.0%
|
$124,070
$38.0 P/Share
|
|
Jan 30
2023
|
Michael J. Davidoff SVP, Payer Business |
SELL
Open market or private sale
|
Direct |
28,555
-10.98%
|
$1,027,980
$36.07 P/Share
|
|
Jan 30
2023
|
Michael J. Davidoff SVP, Payer Business |
BUY
Exercise of conversion of derivative security
|
Direct |
12,090
+4.1%
|
$72,540
$6.37 P/Share
|
|
Jan 18
2023
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
649
-0.5%
|
$23,364
$36.07 P/Share
|
|
Jan 17
2023
|
Michael J. Davidoff SVP, Payer Business |
SELL
Payment of exercise price or tax liability
|
Direct |
2,324
-1.82%
|
$81,340
$35.0 P/Share
|
|
Jan 17
2023
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
1,008
-1.0%
|
$35,280
$35.0 P/Share
|
|
Jan 17
2023
|
Evan Roberts Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,233
-0.31%
|
$78,155
$35.0 P/Share
|
|
Jan 17
2023
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
964
-0.44%
|
$33,740
$35.0 P/Share
|
|
Jan 17
2023
|
Chaim Indig Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
55,346
-4.36%
|
$1,937,110
$35.0 P/Share
|
|
Jan 15
2023
|
Michael J. Davidoff SVP, Payer Business |
BUY
Grant, award, or other acquisition
|
Direct |
31,770
+19.94%
|
-
|
|
Jan 15
2023
|
Michael J. Davidoff SVP, Payer Business |
SELL
Payment of exercise price or tax liability
|
Direct |
9,107
-4.41%
|
$318,745
$35.41 P/Share
|
|
Jan 15
2023
|
Amy Beth Van Duyn SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
19,768
+16.4%
|
-
|
|
Jan 15
2023
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
5,352
-3.13%
|
$187,320
$35.41 P/Share
|
|
Jan 15
2023
|
Evan Roberts Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,184
+5.85%
|
-
|
|
Jan 15
2023
|
Evan Roberts Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,812
-1.42%
|
$693,420
$35.41 P/Share
|
|
Jan 15
2023
|
Randy Rasmussen Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,184
+23.11%
|
-
|
|
Jan 15
2023
|
Randy Rasmussen Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,868
-1.75%
|
$65,380
$35.41 P/Share
|
|
Jan 15
2023
|
David Linetsky SVP, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
45,184
+17.18%
|
-
|
|
Jan 15
2023
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
11,246
-3.09%
|
$393,610
$35.41 P/Share
|
|
Jan 15
2023
|
Allison C Hoffman General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
31,064
+19.27%
|
-
|
|
Jan 15
2023
|
Allison C Hoffman General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,124
-2.1%
|
$74,340
$35.41 P/Share
|
|
Jan 15
2023
|
Chaim Indig Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,601
+5.26%
|
-
|
|
Jan 15
2023
|
Chaim Indig Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
37,193
-1.51%
|
$1,301,755
$35.41 P/Share
|
|
Jan 14
2023
|
Michael J. Davidoff SVP, Payer Business |
SELL
Payment of exercise price or tax liability
|
Direct |
1,239
-1.17%
|
$43,365
$35.41 P/Share
|
|
Jan 14
2023
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
698
-0.8%
|
$24,430
$35.41 P/Share
|
|
Jan 14
2023
|
Evan Roberts Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,816
-0.26%
|
$63,560
$35.41 P/Share
|
|
Jan 14
2023
|
Randy Rasmussen Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,496
-1.38%
|
$52,360
$35.41 P/Share
|
|
Jan 14
2023
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
1,592
-0.86%
|
$55,720
$35.41 P/Share
|
|
Jan 14
2023
|
Allison C Hoffman General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,288
-1.26%
|
$45,080
$35.41 P/Share
|
|
Jan 14
2023
|
Chaim Indig Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,288
-0.27%
|
$115,080
$35.41 P/Share
|
|
Jan 03
2023
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.47%
|
$320,000
$32.22 P/Share
|